A glaucoma medication, methazolamide, has been found to reduce the accumulation of tau protein in zebrafish and mice, offering potential hope for...
Vous n'êtes pas connecté
Learn about how Pomalidomide, a cancer drug, shows promise in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder.
A glaucoma medication, methazolamide, has been found to reduce the accumulation of tau protein in zebrafish and mice, offering potential hope for...
Glaucoma drug methazolamide shows potential in fighting neurodegenerative diseases, offering new hope for treating conditions like Alzheimer's and...
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast...
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3...
Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment particularly challenging. While...
Future Space A newly discovered superluminous nova in the Small Magellanic Cloud has captivated astronomers. Learn how this rare explosion[...]
Learn how employers can support employees navigating cancer treatment and recovery, fostering a compassionate and resilient workplace.
Treating people in low-income countries for major depressive disorder can also help improve their physical health and household members' wellbeing,...
“Discover how grafted tomatoes are transforming Kenyan agriculture! Learn about Nakuru County farmers adopting Chinese grafting technology to boost...